Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Elevance Health (ELV) Q4 CY2024 Highlights: Revenue: $45.44 billion vs analyst estimates of $45.34 billion (6.6% year-on-year growth, in line) Adjusted EPS: $3.84 vs analyst expectations of $3.85 ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...

Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non ...

The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was ...

Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. Later ...

Elevance Health Inc. (ELV) released a profit for fourth quarter that decreased from last year The company's bottom line totaled $418 ...

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice ...